Dubai, UAE: Dubai Airport Freezone Authority (DAFZA) exhibited its state-of-the-art facilities dedicated to the healthcare sector at Arab Health 2020, an event which has taken place from 27-30 January at Dubai World Trade Center.

The DAFZA team showcased its offering to a wide range of international companies that participated in the exhibition, which is considered the largest of its kind for the health care industry in the Middle East and North Africa regions. DAFZA’s aim is to offer support for companies looking to launch their regional operations from the free zone and expand in to global markets. Such businesses are able to maximize the investment opportunities provided by the free zone and the incentives offered. This falls in line with DAFZA’s strategic objective of attracting FDI to the Emirate of Dubai.

During Arab Health, DAFZA highlighted the wide range of packages and licenses that it provides to companies of all different sizes within the healthcare industry. DAFZA also showcased the features of its Light Industrial Units with high cooling capabilities that are compatible with health care and pharmaceutical companies. The 350sqm insulated units can be used as storage and distribution warehouses, with an office on the ground floor. These options serve the different needs of companies in these sectors from size, flexibility, cost efficiency, and competitive rates.

Jamal bin Marghoob, Senior Director of Sales at DAFZA said: “DAFZA’s participation at Arab Health 2020 falls in line with its plans to participate in key regional events, which attract multinational companies seeking to invest or expand in the region. DAFZA provides companies with a wide range of advantages and innovative services that help them access and compete within the regional market.

"The services DAFZA offers suits different types of companies, including those working in the health and medical care sectors. The free zone provides world-class facilities that include state-of-the-art technologies, which keep pace with the rapid development and growth of healthcare companies in the region and across the globe,” added Bin Marghoob.

DAFZA is a regional headquarters for many international companies operating in the healthcare sector, including Johnson & Johnson, Forever Living, Abbot Laboratories, MED-EL Medical Electronics, NSK Middle East, Paul Hartman Middle East, Vygon Middle East, The Himalaya Drug Company, Hetero drugs and many others.

Multinational companies account for a large number of companies within the healthcare sector, pharmaceutical, and health supplies and services based in DAFZA. The free zone provides them with advanced infrastructure for their operations which boost their growth, as well as world-class services and facilities to enhance their operations. 

Ends

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.